Novanta (FRA:1GSN) Valuation Rank


FRA:1GSN Novanta Inc FRA:1GSN
87 GF Score
Price €141.00
GF Value €133.73
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Novanta Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Novanta Valuation Rank Related Terms

FRA:1GSN
87GF Score
Novanta Inc FRA:1GSN
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Novanta (FRA:1GSN) Overvalued in 2026?

Based on GuruFocus' analysis, Novanta stock appears to be overvalued. The current stock price of €141.00 is trading 5.4% above its estimated GF Value™ of €133.73. GuruFocus considers Novanta to be Fairly Valued.

Key valuation signals for FRA:1GSN:

  • Valuation Rank:
  • GF Value™: €133.73 vs. price of €141.00 (5.4% above fair value)
  • GF Score™: 87/100 with 7 warning signs

No single metric tells the full story. See the FRA:1GSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novanta Business Description

Address 125 Middlesex Turnpike, Bedford, MA, USA, 01730
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
87GF Score

Get the complete analysis for FRA:1GSN

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€141.00
Price
€133.73
GF Value